An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of ...

If you have questions about Opdivo for squamous cell lung cancer treatment, talk with your doctor. Is Opdivo approved to treat stage 4 lung cancer? Yes, in certain situations. Stage 4 lung cancer ...

How one man, along with his care team, turned an all-consuming cancer diagnosis into a management strategy with inspiration ...

Q1 2025 Management View Executive Chairman Bill Doyle highlighted the company’s transition to a multi-indication oncology company, emphasizing the regulatory and commercial advancements. He announced ...

NovoCure (NASDAQ:NVCR), a leader in oncology treatments using Tumor Treating ... arrays for NSCLC—non-small cell lung ...

Scientists at Ankara University (AU) have developed an artificial intelligence-supported application that could enable the ...

Non-small cell lung cancer: current treatment and future advances ... our 10-year forecasts for annual sales growth and operating margin remain. We sell different types of products and services ...